Over the past 10 years there has been increased growth and maturity in the compounding technology market and an increased uptake by pharmacies in the use of sterile compounding technologies. Pharmacists and pharmacy technicians, like other caregivers, are increasingly feeling the pressure of a reduced workforce during the pandemic and many are experiencing caregiver burnout which can directly impact compounding success. Together, pharmacists and technicians must address these challenges to improve the safety of sterile compounding practices as well as continue to increase the safe use of technology in the process.
Join as faculty describe common challenges faced by technicians using technology in the sterile compounding process and the role that technicians play in helping to design a safe workflow plan. ISMP's new sterile compounding best practice guidelines for 2022 from ISMP will be reviewed as part of the program.
The intended audience includes: Pharmacists and Pharmacy Technicians involved in Sterile Compounding, Administrators with oversight of Pharmacy Practice, Medication Safety Officers, Quality Improvement and Risk Management professionals, Pharmacy Faculty and Students. Upon completion of this activity, participants will be able to:
- State common safety challenges faced by technicians using sterile compounding technology.
- Explain the role of the technician in designing a safe workflow plan for sterile compounding technology.
- Discuss best practices identified during ISMP's National Sterile Compounding Summit.
Elham Amiri, CPhT, Pharmacy Technician, UCSF
Christina Michalek, BSc Pharm, RPh, FASHP, Director, Membership and PSO, ISMP
Release Date: June 7, 2022
Expiration Date: June 7, 2024
Pharmacists and Pharmacy Technicians
This CE activity is jointly provided by ProCE, LLC and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-22-195-H05-P/T has been assigned to this knowledge-based home-study CE activity. This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Elham Amiri, CPhT, and Christina Michalek, BSc Pharm, RPh, FASHP, do not have any relevant commercial and/or financial relationships to disclose.
This CE activity is supported by an educational grant from Baxter.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.